Urticaria, angio-oedema and anaphylaxis are distinct clinical entities caused by transient plasma leakage from small blood vessels. When the affected vessels are superficial the result is a raised, itchy swelling of the skin known as a weal. Involvement of deeper vessels produces tender subcutaneous and submucosal swellings known as angio-oedema. Generalised plasma exudation leading to shock is a feature of anaphylaxis but also occurs in anaphylactoid reactions and the capillary leak syndrome.
Definitions
Urticaria is an eruption of transient superficial itchy weals, pale or pink in colour which may have a surrounding flare of redness. They may be few in number or numerous and widespread. Their size varies from a few millimetres to many centimetres. The hallmark of urticaria is its rapid fluctuation. Individual lesions come and go within 24 hours, but the eruption of fresh weals means that the whole attack may last much longer.
Urticarial lesions (ie areas of superficial swelling) are also seen in skin diseases other than urticaria (eg some drug reactions, bullous pemphigoid). In these conditions, the lesions do not show the rapid fluctuation which characterises urticaria. They will not be considered further in this article.
Angio-oedema implies deeper vascular leakage producing swellings predominantly affecting the subcutis. They tend to be large, pale and painful rather than red and itchy, and last longer than weals. Angio-oedema is a cause of distressing oropharyngeal swellings but may occur anywhere on the integument including the genitalia.
Anaphylaxis is defined by a life-threatening fall in blood pressure, difficulty with breathing or both. Other features, including widespread redness, itching and urticaria may occur (Table 1) . True anaphylaxis is due to an allergic reaction involving allergen-specific immunoglobulin (Ig) E. Anaphylactoid reactions present similarly but do not involve IgE.
Classification of urticaria and angio-oedema
It is helpful to divide urticaria into different clinical categories for the purpose of management. Many acute cases are short-lived or episodic but recurrent urticaria that continues at least twice a week for over six weeks is defined as chronic.
The simplest working classification is to separate urticarias into four categories (Table 2) : ordinary physical vasculitic urticaria (urticarial vasculitis) contact urticaria.
Angio-oedema may be a feature of most patterns of urticaria and, for the most part, can be considered together with urticaria. However, it is worth considering angio-oedema separately when it occurs without weals (Table 3) because it may then be a presentation of C1 esterase inhibitor (C1 inh) deficiency or a drug reaction.
Ordinary urticaria
Ordinary urticaria is a useful collective term for all recurring urticarias that do not fall into the other three categories, in that they:
do 
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The common clinical feature of ordinary urticaria is that individual weals last less than 24 hours before disappearing completely without residual colour or texture change in the skin. The general health of the patient remains good but systemic symptoms such as lethargy, malaise and indigestion are quite common during severe attacks.
Physical urticaria
Physical urticaria is defined by the nature of the physical stimulus that reproducibly gives rise to urticaria. Weals typically fade within 30-60 minutes. The exception is delayed pressure urticaria when the weals take several hours to appear after sustained pressure and can last up to 48 hours. The morphology and distribution of the weals can also be helpful in identifying the trigger. Coldinduced urticaria, for instance, occurs on exposed skin or on immersion in cold water and may rarely progress to anaphylaxis. Cholinergic urticaria (due to a rise in core temperature) is mainly truncal. Delayed pressure urticaria predominates wherever there is sustained pressure (eg under belts or straps).
Vasculitic urticaria
In vasculitic urticaria there are urticarialike lesions caused by underlying leukocytoclastic vasculitis. Subtle features which distinguish them from ordinary urticaria are pain, individual lesion duration longer than 24 hours and bruise-like discolouration or petechiae during resolution. This condition is usually idiopathic, but may be associated with systemic lupus erythematosus.
Contact urticaria
Contact urticaria occurs at the site of skin or mucosal contact with an agent that provokes increased vascular permeability. The cause can be either allergic (eg allergy to natural rubber latex) or non-allergic. Certain chemicals in foods and cosmetics can cause localised urticaria without involving specific IgE. Affected individuals often make their own diagnosis and learn what to avoid because symptoms develop almost immediately after exposure.
Aetiology and pathogenesis
The release of histamine and other mediators from mast cells provokes vascular leakage responsible for the tissue swelling of urticaria and angio-oedema and the catastrophic vascular exudation of anaphylaxis. Mast cell activation may be allergic or non-allergic. The pathogenetic mechanisms responsible are shown in Table 4 . There is poor correlation between patho-mechanism and clinical type. For instance, IgE-mediated allergy can present with localised contact urticaria, generalised urticarial weals or anaphylaxis depending on the type of exposure and the degree of hypersensitivity. No cause can be identified in 50% of acute urticaria. In the others, the commonest preceding event is an upper respiratory infection or a reaction (not necessarily an allergy) to a drug or food 1 . Chronic urticaria is rarely, if ever, allergic in the sense of a defined environmental allergen being the cause, but 'pseudoallergic' reactions to dietary additives and natural salicylates may be important in some cases 2 . Up to 50% of cases presenting with ordinary urticaria may be due to the recently recognised 'autoimmune' urticaria 3 . Underlying systemic disease (unless suspected on the patient's history) almost never emerges as the cause of ordinary urticaria even when long-standing.
Urticarial vasculitis results from immune complexes lodging in small blood vessels (type III hypersensitivity), generating C3a and C5a anaphylatoxins which are potent mast cell degranulators.
The angio-oedema of C1 inh deficiency is due to production of kinin-like peptides from C2. They cause vasopermeability without mast cell degranulation.
Anaphylactic reactions are always caused by type I IgE-mediated immediate hypersensitivity reactions.
With weals
Angio-oedema may occur in all forms of urticaria except dermographism
Without weals idiopathic drugs (ACEIs, NSAIDs) C1 inh deficiency (hereditary and acquired) ACEI = angiotensin-converting enzyme inhibitor; C1 inh = C1 esterase inhibitor; NSAID = non-steroidal anti-inflammatory drug. 
Management
Avoiding the cause of the urticaria is fundamental to preventing anaphylaxis but is often not possible in both urticaria and angio-oedema. It is nevertheless helpful to recognise trigger factors in physical urticarias and non-specific aggravating factors in ordinary urticaria such as stress, aspirin, overheating and alcohol. Cooling creams, such as 0.5% menthol in aqueous cream, are often soothing.
Despite advances in the range and scope of pharmacological treatments for urticaria, the emergency treatment of acute severe attacks still hinges on systemic antihistamines and steroids. Intramuscular adrenaline may be lifesaving for anaphylaxis and the occasional attack of pharyngeal angiooedema. Patients with known C1 inh deficiency presenting with angiooedema of the mouth or bowel should be managed with an infusion of purified C1 inh or of fresh frozen plasma (3 units) if the inhibitor concentrate is not available. (Table 6) The treatment of chronic urticaria is neither straightforward nor simple because the condition often lasts for years. Regular oral antihistamines should be given at full dose as first-line therapy for all patients. The nonsedating second-generation H 1 antagonists are the treatment of choice for most patients because 'classical' antihistamines often cause unacceptable daytime sedation or reduced ability to perform skilled tasks 5 . They are best given at night when itch and weals are often troublesome, with or without a regular nonsedating antihistamine by day. The addition of an H 2 antagonist, such as ranitidine, can provide additional symptomatic control for some patients. The new third-generation antihistamine, desloratadine, has high affinity for the H 1 receptor and additional 'anti-allergic' effects in vitro, but it remains to be seen whether it controls urticaria better than older drugs.
Pharmacological management
Many second-line therapies are available for urticaria that is poorly controlled with antihistamines, but the Non-immunological Direct mast cell releasing agents (eg opiates) NSAIDs and dietary pseudoallergens ACEIs ACEI = angiotensin-converting enzyme inhibitor; C1 inh = C1 esterase inhibitor; Ig = immunoglobulin; NSAID = non-steroidal anti-inflammatory drug. Ordinary:
Urticarial vasculitis Lower leg cellulitis is a common reason for urgent medical admission; it often results in prolonged hospitalisation and significant long-term morbidity [1] [2] [3] [4] [5] .
Clinical features
Cellulitis is deeply situated inflammation of the skin and subcutaneous tissue, usually due to an infection. The distinction from erysipelas, which is more superficial and thus has more sharply demarcated margins, is somewhat artificial on the leg.
Typical lower leg cellulitis is characterised by progressive painful swelling and erythema (Fig 1) with pyrexia and general malaise which are often present before the localising signs. Blistering and ulceration may occur, usually if oedema is marked.
Bacteriology
Most patients with proximally spreading lower leg cellulitis have streptococcal infection [1] [2] [3] [4] [5] . Group A streptococci are most important but groups C and G organisms are also common at this site. Staphylococcal cellulitis is usually more localised but can mimic streptococcal disease. Other infections 1, 3 are much less common at this site but should be considered, particularly in the following situations: diabetes, immunosuppression or hepatic cirrhosis localised cellulitis penetrating injury or animal bite preceding ulceration recent foreign travel cellulitis at other body sites or in children.
Predisposing factors
Toeweb maceration is a common portal of entry for streptococci in lower leg cellulitis (Fig 2) , while tinea pedis is a major factor in patients with recurrent episodes 5, 6 . Mycology cultures from macerated toewebs are important (note that athlete's foot fungi do not fluoresce and cannot be detected using Wood's light).
Lower leg oedema of any causation is a risk factor. Lymphoedema is especially important as a cause of recurrent episodes 6 and is a situation in which streptococcal cellulitis can be particularly aggressive.
Other risk factors include obesity, recent surgery (especially venectomy for coronary artery bypass grafting) and preceding venous eczema or leg ulceration 6 . Blunt injury 5 
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evidence for their use is generally weak 6 . It is usually advisable to seek the help of a specialist urticaria clinic at this stage to define the urticarial subgroup. Some types may be more likely to respond to novel approaches, including the use of immunosuppressive drugs for patients with the most severe forms of autoimmune urticaria.
Prognosis
Many cases of urticaria are short-lived, lasting days or weeks. About 50% of patients with ordinary urticaria can be expected to have cleared by six months. The outlook for those with urticaria and angio-oedema is less encouraging since 50% will still have their condition five years later 7 . Urticarial vasculitis is likely to persist or recur over many years.
